Consequently, IL-23 (p19) or the IL-23 receptor (IL-23R) deficient mice are resistant to autoimmune and inflammatory disorders, such as experimental autoimmune encephalomyelitis13, collagen-induced arthritis14 and inflammatory bowel disease (IBD)15,16. Here, IL23A is linked to inflammatory bowel disease.